HUTCHMED (China) (HMDCF) Exchange Rate Effect (2018 - 2021)
HUTCHMED (China)'s (HMDCF) quarterly Exchange Rate Effect came in at $1.1 million in Q2 2021, up 2582.22% year-over-year from $41644.6 in Q2 2020, and up 359.77% quarter-over-quarter from -$430000.0 in Q1 2021.
Analysis
HUTCHMED (China) (HMDCF) Exchange Rate Effect (2018 - 2021) Analysis & Trends
HUTCHMED (China) (HMDCF) has reported Exchange Rate Effect for 4 consecutive years, with $1.1 million the latest figure, recorded in Q2 2021.
- On a quarterly basis, Exchange Rate Effect rose 2582.22% year-over-year to $1.1 million in Q2 2021; TTM through Jun 2021 was $624000.0, a 147.63% increase from a year earlier, with the FY2025 full-year figure at $3.6 million, up 205.94% from the prior year.
- Exchange Rate Effect was $1.1 million for Q2 2021 at HUTCHMED (China), up from -$430000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $3.9 million in Q4 2018 and troughed at -$2.7 million in Q3 2018.
- A 4-year average of $85416.7 and a median of -$31500.0 in 2020 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 2582.22% in 2021, down 2288.89% in 2021.
- Over 4 years, Exchange Rate Effect stood at $3.9 million in 2018, then plunged by 91.24% to $338000.0 in 2019, then sank by 113.31% to -$45000.0 in 2020, then jumped by 2582.22% to $1.1 million in 2021.
- The last three Exchange Rate Effect figures came in at $1.1 million (Q2 2021), -$430000.0 (Q1 2021), and -$45000.0 (Q2 2020), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.37 Bn | 197.38 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 181.12 Bn | 177.94 Bn | 6.22 Bn | -19.00 Mn |
| 3 | Vertex Pharmaceuticals | 132.11 Bn | 124.26 Bn | 2.84 Bn | -3.70 Mn |
| 4 | Regeneron Pharmaceuticals | 82.51 Bn | 74.52 Bn | 3.93 Bn | -300,000.00 |
| 5 | Argenx Se | 61.69 Bn | 56.50 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.62 Bn | 49.48 Bn | 52.00 Mn | -2.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.14 Bn | 30.84 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Biogen | 31.29 Bn | 30.01 Bn | 1.96 Bn | -3.40 Mn |
| 9 | Roivant Sciences | 30.09 Bn | 30.09 Bn | 1.16 Mn | 315,000.00 |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | 1.12 Mn |
| Mar 31, 2021 | -430,000.00 |
| Jun 30, 2020 | -45,000.00 |
| Mar 31, 2020 | -18,000.00 |
| Dec 31, 2019 | 338,000.00 |
| Sep 30, 2019 | -1.59 Mn |
| Jun 30, 2019 | -1.80 Mn |
| Mar 31, 2019 | 1.54 Mn |
| Dec 31, 2018 | 3.86 Mn |
| Sep 30, 2018 | -2.67 Mn |
| Jun 30, 2018 | -479,000.00 |
| Mar 31, 2018 | 1.19 Mn |